Combioxin is a Swiss-based biotechnology company dedicated to the development of first-in-class life-saving drugs for severe infections.
The company is currently running two parallel programs on an innovative technology designed to fight severe bacterial and viral infections.
Combioxin aims at becoming a market leader in non-traditional therapies for severe and resistant infections.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.